Preven ng Pharmaceu cal Pollu on and Diversion
Kate Hagemann & Sierra Fletcher Product Stewardship Ins tute How to Participate Today
• Open and close your Panel • View, Select, and Test your audio • Submit text questions • Raise your hand
• Q&A addressed at the end of today’s session
• Everyone will receive an email within 24 hours with a link to view a recorded version of today’s session Who is the Product Stewardship Ins tute?
§ Non-profit founded in 2000 § Membership ü 47 States ü 200+ Local governments ü 70+ Corporate, Organiza onal, Academic & Non-U.S. Government Partners § Board of Directors: 7 states, 4 local agencies • Mul -stakeholder product stewardship network
3 The Problem: Waste Pharmaceu cals
1. Environmental Concerns
2. Drug Diversion concerns
3. Public Safety Concerns
4 1. Environmental Concerns
• Effects in the environment: – Endocrine disruptors – An bio c resistance • Pharmaceu cals enter the environment via a number of channels – Agricultural run-off – Human excre on – Improper disposal • Current waste water treatment plants cannot remove pharmaceu cal compounds
April 15, 2011 5 Evidence of pharmaceu cals In our waterways
• Minnesota Pollu on Control Agency (2011) • USGS (June 2002)
•“a broad range of chemicals found in residen al, industrial, and agricultural wastewaters commonly occurs in mixtures at low concentra ons downstream from areas of intense urbaniza on and animal produc on. The chemicals include human and veterinary drugs (including an bio cs), natural and synthe c hormones, detergent metabolites, plas cizers, insec cides, and fire retardants. One or more of these chemicals were found in 80 percent of the streams sampled”
April 15, 2011 6 Environmental Impacts
• Ecological impacts remain unknown • Observed impacts: – Abnormali es – Disrupts reproduc ve systems/risk of ex nc on • Baylor University researchers found residues human medica ons in fish. Include an histamines, high blood pressure medica on& an -depressants
"These results demonstrate the increasing need to consider bioaccumula on of emerging contaminants in the environment," said Dr. Kevin Chambliss, an assistant professor of chemistry at Baylor, who is a co-lead inves gator on the project. "This research proves fish are being exposed to mul ple compounds in our waterways."
April 15, 2011 7 Impacts on Human Health
• Largely unknown • Effects of chronic exposure to low-levels of contamina on underexplored in toxicology
April 15, 2011 8 What’s wrong with the trash?
• Drugs disposed of in the trash s ll are released into the environment through the runoff from landfills known as “leachate”
April 15, 2011 9 Clear & Consistent Message
10 January 24, 2011 2. Drug Diversion Concerns
• Prescrip on Drug Abuse is “the fastest growing drug problem” according to the Obama administra on • Accidental drug overdoses are now the leading cause of death in 17 states – Average of 7 people die everyday in Florida • 7 out of 10 prescrip on drug abusers obtained their drugs from friends or rela ves
11
Drug-Induced Deaths Second Only to Motor Vehicle Fatali es, 1999–2007
Motor vehicle fatali es
Drug-induced deaths Suicides
Gunshot deaths
Homicides
Source: Na onal Center for Health Sta s cs, Centers for Disease Control and Preven on. Na onal Vital Sta s cs Reports Deaths: Final Data for the years 1999 to 2007 (2001 to 2010). Uninten onal Drug Overdose Deaths United States, 1970-2007
In 2007, there were 9.18 deaths per 100,000 popula on due to uninten onal drug overdose, based on 27,658 deaths.
Source: Centers for Disease Control and Preven on. Uninten onal Drug Poisoning in the United States (July 2010). Safety Concerns
• Storing le over/expired medica ons in the home increases the risk of accidental poisoning and/or taking the wrong medica on
• Children, the elderly and pets are par cuarly vulnerable
14 Need for safe disposal op ons
• collec on programs opera ng around the country: •Household hazardous waste facili es •Pharmacies •Police sta ons •One-day collec on events
© Product Stewardship Institute – February 25, 2011 15 Drug Take–Back Legisla on in the U.S. 2009 -2011
16 EPR for Pharmaceu cals – Legisla on in the U.S. 2009 -2011
• “study bills” in CA, VT, RI • other take-back legislation in a dozen states • potential federal bill
17 Poten al Roles in EPR: Pharmaceu cals
• Mandated • Manufacturers (“pharma”) develop and implement take-back program – Would choose combina on of available mechanisms (i.e., law enforcement involved as long as that is s ll required) – Meet program minimum requirements/goals • Government oversees program & enforces against non- compliant manufacturers – Educa on & outreach • Retail pharmacies could serve as collec on sites • Consumers get informa on about what to do with le over drugs & dispose accordingly (no, this part isn’t easy!)
18 Post Consumer Pharmaceu cal Stewardship Associa on - Canada
– Mandatory Programs: • Bri sh Columbia – Established in 2000 – more than 97.5% of all pharmacies are par cipa ng in the program (voluntarily) – pa ents have access to over 1080 collec on loca ons
• Manitoba – Established in February 2010
19 Companies Participating in PCPSA
1. Abbo Laboratories Limited 42. Holista Health Canada 83. Pla num Naturals 2. Abraxis BioScience 43. Hospira Healthcare Corpora on 84. Procter & Gamble Inc. 3. Actelion Pharmaceu cals Canada Inc. 44. Hudson’s Bay Company 85. Proctor & Gamble Pharmaceu cals Canada Inc 4. Advantage CKN 45. Indigene Pharma Inc. 86. ProMedics Nutraceu cal Ltd 5. Afexa Life Sciences Inc. 46. Ins tut Rosell 87. Purdue Pharma 6. Alcon Canada 47. Jamieson Laboratories Ltd. 88. Ranbaxy Pharmaceu cals Canada Inc. 7. Amgen Canada Inc. 48. Janssen-Ortho Inc. 89. Ra opharm 8. Amway Canada 49. Johnson & Johnson Inc. 90. Rivex Pharma Inc. 9. Apotex Inc. 50. Katz Group Canada Ltd 91. Roche Canada 10. Ashbury Biologicals Inc. 51. King Pharmaceu cals 92. Ropack Inc. 11. Astellas Pharma 52. Kripps Pharmacy 93. Sanofi-Aven s Canada Inc. 12. AstraZeneca Canada Inc. 53. Laboratoire RIVA Inc. 94. Sandoz Canada 13. Au Naturel Inc. 54. Leo Pharma Inc. 95. Schering Canada Inc. 14. Axcan Pharma Inc. 55. Loblaw Companies Ltd 96. Seaford Pharmaceu cals 15. Bayer Inc. 56. London Drugs Limited 97. Sepracor Pharmaceu cals Inc. 16. Baxter Canada 57. Lundbeck Canada Inc. 98. Servier Canada Inc. 17. Bioforce Canada 58. Mead Johnson Nutri onals 99. Shaklee Canada Inc. 18. Biogen Idec Canada Inc. 59. Mentholatum Co. of Canada Ltd. 100. Shire Canada Inc. 19. Biovail Pharmaceu cals Canada 60. Merck Frosst Canada & Co. 101. Shoppers Drug Mart, Pharmaprix 20. Boehringer Ingelheim Canada Ltd. 61. Mylan Canada 102. SISU Inc. 21. Boiron 62. Natural Factors Nutri onal Products Ltd. 103. Solvay Pharma Inc. 22. Bristol-Myers Squibb Pharmaceu cal Group 63. Nature's Sunshine Products 104. S efel Canada Inc. 23. Canada Safeway Ltd. 64. Novar s Consumer Health Canada Inc. 105. Swiss Herbal Remedies Ltd. 24. Cha em (Canada) Inc. 65. Novar s Pharma Canada Inc. 106. Taro Pharmaceu cals Inc. 25. Church & Dwight Canada 66. Novo Nordisk Canada Inc 107. Tianshi Health Products 26. Cobalt Pharmaceu cals Inc. 67. Novopharm Ltd. / Teva Neuroscience 108. Trophic Canada 27. Combe Incorporated 68. Nu-Pharm Inc 109. UniPHARM Wholesale Drugs 28. Costco 69. Nucro-Technics Incorporated 110. USANA Canada Co. 29. Cytex Pharmaceu cal Inc. 70. Nycomed Canada Inc. 111. Valeant Canada Limited 30. Eli Lilly Canada Inc. 71. Odan Laboratories 112. Vita Health Products Inc. 31. EMD-Serono Canada Inc 72. Omega Alpha Pharmaceu cals 113. Wal-Mart Pharmacy 32. Enzyma c Therapy 73. Omega Laboratories 114. Wellspring Pharmaceu cals 33. Ferring Inc. 74. Organika Health Products Inc. 115. Westcoast Naturals 34. Gaia Garden Herbal Inc. 75. Overwaitea Food Group Ltd Partnership 116. WN Pharmaceu cals Ltd. 35. Galderma Ltd 76. Paladin Labs Inc. 117. Wyeth Consumer Healthcare Inc. 36. General Nutri on Centres Canada 77. Patheon Inc. 118. Wyeth - Canada 37. GlaxoSmithKline Consumer Healthcare 78. Peoples Drug Mart 38. GlaxoSmithKline Inc. 79. Pfizer Canada Inc 39. Graceway Pharmaceu cals 80. Pharmasave 40. Helix BioPharma Corp. 81. Pharmascience Inc. 41. Herbalife of Canada 82. PharmEng Technology Inc. Par cipa ng Companies – A Few Examples
• Abbo Laboratories Limited • Bayer Inc. • Bristol-Myers Squibb • Eli Lilly Canada Inc. • GlaxoSmithKline Inc. • Johnson & Johnson Inc. • Pfizer Canada Inc • Procter & Gamble Inc. • Wal-Mart Pharmacy
21 Upcoming Webinars
Preven ng Pharmaceu cal Pollu on and Diversion - Spotlight on Iowa Again: May 3rd at 2-3 Central
Learning from Canada: Post Consumer Pharmaceu cal Stewardship Associa on Thursday May 5th 4-5pm Eastern/ 3-4pm Central
Gine e Vanasse, Post Consumer Pharmaceu cal Stewardship Associa on
22 Contact
Sierra Fletcher PSI Director of Policy & Programs 617-236-4886 [email protected]
www.productstewardship.us
23 Iowa’s medica on disposal program – Update April 2011
Background • 2009 & 2010 Iowa state legisla on – Funding $150,000
• Joint venture between: – Iowa Board of Pharmacy – Iowa Pharmacy Associa on (IPA) – 400+ community pharmacies – 20+ statewide partnering organiza ons Iowa’s Solu on • IPA partnered with Sharps Compliance, Inc. – Located near Houston, TX – Specialize in medical and pharmaceu cal waste disposal for 15 years
• TakeAway™ Environmental Return System – Turn-key pharmaceu cal waste disposal program – U lize Iowa community pharmacies TakeAway™ Program • TakeAway systems – 10 and 20 gallons – Plas c-lined, heavy-duty cardboard, tamper-resistant, one way entry – 9’’ x 12’’ TakeAway envelopes* • Unacceptable items – Controlled substances – Liquids > 4 oz – Non-drug products TakeAway™ Program • Return shipment for systems and envelopes – Pre-addressed, pre-paid to Sharps in TX – Compliant with DEA, UPS, USPS
• Disposal – Waste-to-energy incinera on – Witnessed by law enforcement – Systems and envelopes sealed up to and during incinera on Using the TakeAway™ Program • Gather all unwanted and expired medica ons – Leave medica ons in vials and packaging – Do NOT include controlled substances
• Bring to a par cipa ng pharmacy ( www.iarx.org/takeaway) – TakeAway system kept behind the counter* – Personal informa on remains confiden al TakeAway™ Program in Iowa • Every Iowa community pharmacy eligible – 414 pharmacies in all 99 coun es par cipa ng
• Par cipa ng pharmacies receive: – TakeAway systems** – Customizable marke ng materials – Business plan for sustaining the program
Since the launch… • 309 pharmacies on Nov 1; >100 joined ‘post-launch’ • Successful public educa on/media campaign(s) – Pharmacy driven – Outside-In – Earth Week/Spring Cleaning 2010 – Public Rela ons Campaign 2011 (ongoing) • Pill Dude • Updated Pharmacy materials • Partner events with law enforcement for CS
2011 • As of April 3, 2011 (~18 months) – 608 returned TakeAway systems (20 gal) – 1,416.1 lbs of returned medica ons incinerated (tared weight) – 15,840 lbs of returned medica ons collected by pharmacies**
• Partner with NCPA – na onal TakeAway ini a ve www.disposemymeds.org • Seeking another year of Legisla ve funding or sustainable funding from other source(s)
Iowa’s medica on disposal program u lizing community pharmacies www.iarx.org/takeaway Kate Gainer, PharmD Vice President, Professional Affairs Iowa Pharmacy Association [email protected]
www.iarx.org/takeaway